Z. Xing, H.-C. Wang, Y. Cheng, C. Zhu, T. D. James, J. Zhao
FULL PAPER
S-5b: A similar procedure was applied. 1H NMR (300 MHz,
CDCl3): δ = 1.11–1.26 (m, 11 H), 1.37 (s, 9 H), 2.32 (m, 2 H), 3.01
(q, J = 7.2 Hz, 2 H), 3.63 (q, J = 6.6 Hz, 1 H), 3.72 (s, 3 H), 6.78–
CDCl3): δ = 1.22–1.47 (m, 8 H), 2.50 (t, J = 7.2 Hz, 2 H), 2.68 (t,
J = 7.2 Hz, 2 H), 3.66 (s, 2 H), 4.37 (s, 2 H), 7.22 (s, 5 H), 7.87–
8.27 (m, 9 H) ppm. 13C NMR (75 MHz, CDCl3): δ = 140.5, 134.1,
6.80 (d, J = 8.3 Hz, 2 H), 7.13–7.16 (d, J = 8.3 Hz, 2 H) ppm. 13C 131.3, 130.8, 130.6, 129.0, 128.4, 128.1, 127.6, 127.5, 127.0, 127.0,
NMR (75 MHz, CDCl3): δ = 158.4, 140.0, 138.0, 127.6, 126.7,
126.9, 125.9, 125.0, 125.0, 124.9, 124.7, 123.1, 77.5, 77.1, 76.6, 54.1,
113.8, 113.7, 79.1, 77.5, 77.1, 76.6, 57.7, 55.3, 55.3, 50.7, 47.8, 30.2, 51.9, 50.0, 49.4, 30.1, 30.1, 27.3, 27.3 ppm. HRMS (ESI): calcd. for
28.5, 27.1, 26.7, 25.8, 24.4 ppm. HRMS (ESI): calcd. for
C30H32N2Na [M + H]+ 443.2463; found 443.2472.
C20H35N2O3 [M + H]+ 351.2647; found 351.2738.
Compound 8b: Synthesized according to the same method as 8a.
1H NMR (300 MHz, CDCl3): δ = 1.22–1.55 (m, 8 H), 2.40 (t, J =
7.2 Hz, 2 H), 2.52 (t, J = 7.2 Hz, 2 H), 3.48 (s, 2 H), 3.67 (s, 3 H),
4.25 (s, 2 H), 7.22 (s, 5 H), 6.74–6.77 (d, J = 7.2 Hz, 2 H) 7.82–
8.37 (m, 11 H) ppm. 13C NMR (75 MHz, CDCl3): δ = 167.1, 145.9,
134.2, 131.3, 130.8, 130.6, 129.7, 129.0, 128.7, 127.9, 127.6, 127.5,
127.0, 127.0, 125.9, 125.1, 124.9, 124.7, 123.2, 77.5, 77.0, 76.6, 53.7,
52.0, 51.9, 49.9, 49.4, 30.1, 30.0, 27.3, 27.2 ppm. HRMS (ESI):
calcd. for C31H35N2O [M + H]+ 451.2749; found 451.2766.
N-{1-(4-Methoxyphenyl)ethyl}-NЈ-(pyren-1-ylmethyl)hexane-1,6-di-
amine (6b). R-6b: A similar procedure was applied as described for
R-6a. H NMR (300 MHz, CDCl3): δ = 1.30–1.60 (m, 11 H), 2.40
1
(m, 2 H), 2.76 (t, J = 7.2 Hz, 2 H), 3.68 (q, J = 6.6 Hz, 1 H), 3.78
(s, 3 H), 4.47 (s, 2 H), 6.84–6.87 (d, J = 8.3 Hz, 2 H), 7.20–7.23 (d,
J = 8.3 Hz, 2 H), 7.97–8.37 (m, 9 H) ppm. 13C NMR (75 MHz,
CDCl3): δ = 158.5, 137.9, 134.1, 131.3, 130.87, 130.6, 129.1, 127.6,
127.6, 127.5, 127.0, 127.0, 125.9, 125.1, 125.0, 124.9, 124.7, 123.2,
113.7, 77.5, 77.1, 76.6, 57.7, 55.2, 51.9, 50.0, 47.8, 30.2, 30.1, 27.3,
24.4 ppm. HRMS (ESI): calcd. for C32H37N2O [M + H]+ 465.2905;
R-1: A mixture of N-[(1R)-1-(naphthalen-1-yl)ethyl]-NЈ-(pyren-1-
ylmethyl)hexane-1,6-diamine (100 mg, 0.21 mmol), K2CO3 (85 mg,
0.62 mmol) and [2-(bromomethyl)phenyl]boronic acid pinacol ester
(135 mg, 0.46 mmol) in dry MeCN was heated to reflux for 8 h.
The reaction mixture was cooled to room temperature, and the
solvent was removed under vacuum. The residue was taken up with
H2O (10 mL), the aqueous phase was extracted with CH2Cl2
(3ϫ30 mL), and the organic phase was washed with brine
(2ϫ20 mL) and dried with anhydrous MgSO4. The solvent was
removed under vacuum, and the residue was chromatographed (sil-
ica gel; CH2Cl2/MeOH, 10:1, v/v). R-1 was obtained as a pale yel-
low powder. Yield: 38.0%. 1H NMR (300 MHz, CDCl3): δ = 0.89–
1.46 (m, 8 H), 1.29 (s, 3 H), 1.36 (s, 24 H), 2.37–2.39 (m, 2 H),
2.42–2.44 (m, 2 H), 3.93–3.99 (m, 2 H), 4.15 (s, 2 H), 4.19 (m, 2
H), 4.60–4.64 (m, 1 H), 7.24–7.62 (m, 10 H), 7.70–7.79 (m, 2 H),
8.00–8.16 (m, 11 H), 8.30–8.34 (m, 1 H) ppm. 13C NMR (75 MHz,
CDCl3): δ = 146.4, 145.6 140.5, 135.3, 133.9, 132.2, 131.3, 130.9,
129.9, 128.7, 128.3, 127.5, 127.0, 126.8, 126.7, 125.7, 125.3, 125.1,
125.0, 124.9, 124.7, 124.5, 124.3, 122.9, 122.5, 83.4, 57.8, 56.8, 55.7,
54.3, 53.6, 50.3, 30.1, 27.2, 25.7, 25.0, 24.9 ppm. HRMS (ESI):
calcd. for C61H71B2N2O4 [M + H]+ 917.5599; found 917.5606.
[α]2D2 = –34Ϯ1 (c = 1.0; CH3OH/CH2Cl2, 1:1).
1
found 465.2907. S-6b: A similar procedure was applied. H NMR
(300 MHz, CDCl3): δ = 1.32–1.58 (m, 11 H), 2.43 (m, 2 H), 2.77
(t, J = 7.2 Hz, 2 H), 3.70 (q, J = 6.6 Hz, 1 H), 3.78 (s, 3 H), 4.47
(s, 2 H), 6.85–6.88 (d, J = 8.3 Hz, 2 H), 7.21–7.26 (d, J = 8.3 Hz,
2 H), 7.99–8.38 (m, 9 H) ppm. 13C NMR (75 MHz, CDCl3): δ =
158.5, 137.9, 134.2, 131.3, 130.8, 130.6, 129.0, 127.6, 127.5, 127.5,
127.0, 126.9, 125.8, 125.1, 124.9, 124.9, 124.7, 123.2, 113.7, 77.5,
77.0, 76.6, 57.7, 55.2, 51.9, 50.0, 47.8, 30.2, 30.1, 27.3, 24.3 ppm.
HRMS (ESI): calcd. for C32H36N2NaO [M + H]+ 487.2725; found
487.2723.
tert-Butyl N-(6-{[(Pyren-1-ylmethyl)amino}hexyl)carbamate (7):
tert-Butyl N-(6-aminohexyl)carbamate (2.0 g, 9.25 mmol) was dis-
solved in MeOH/CH2Cl2 (1:3, v/v). To this solution was added a
solution of pyrene-1-carbaldehyde (2.13 g, 9.26 mmol) in MeOH/
CH2Cl2 (10 mL). The mixture was heated to reflux for 6 h. NaBH4
(0.55 g, 14.5 mmol) was added in small portions, and the mixture
was stirred at room temp. for 4 h. The solvent was removed under
reduced pressure, the residue was taken up with CH2Cl2, and the
organic phase was washed with saturated NaCl solution
(3ϫ50 mL). The organic phase was dried with anhydrous Na2SO4,
concentrated to dryness, and the residue was chromatographed (sil-
ica gel; hexane/ethyl acetate, 20:1, v/v). Compound 7 (3.0 g, 74.9%)
S-1: Synthesized according to the same method. 1H NMR
(300 MHz, CDCl3): δ = 0.91–1.46 (m, 8 H), 1.11 (s, 3 H), 1.36 (s,
24 H), 2.37–2.39 (m, 2 H), 2.42–2.52 (m, 2 H), 3.96–4.00 (m, 2 H),
4.01 (s, 2 H), 4.17–4.21 (m, 2 H), 4.52–4.66 (m, 1 H), 7.26–7.57 (m,
10 H), 7.59–7.85 (m, 2 H), 7.97–8.16 (m, 11 H), 8.33–8.36 (m, 1 H)
ppm. 13C NMR (75 MHz, CDCl3): δ = 147.9, 146.4, 140.5, 135.3,
133.9, 132.2, 131.3, 130.9, 129.9, 128.7, 128.3, 127.5, 127.0, 126.8,
126.7, 125.7, 125.3, 125.1, 125.0, 124.9, 124.7, 124.5, 124.30, 122.9,
122.5, 83.6, 57.8, 56.0, 55.7, 53.8, 50.3, 47.9, 30.4, 27.3, 25.7, 25.0,
23.6 ppm. HRMS (ESI): calcd. for C61H71B2N2O4 [M + H]+
917.5599; found 917.5631. [α]2D2 = +33Ϯ1 (c = 1.0; CH3OH/
CH2Cl2, 1:1).
1
was obtained as a yellow solid. H NMR (300 MHz, CDCl3): δ =
1.29–1.55 (m, 17 H), 2.76 (t, J = 7.2 Hz, 2 H), 3.07 (q, J = 6.6 Hz,
2 H), 4.46 (s, 2 H), 7.97–8.37 (m, 9 H) ppm. 13C NMR (75 MHz,
CDCl3): δ = 156.0, 134.1, 131.3, 130.8, 130.6, 129.0, 127.6, 127.5,
127.0, 127.0, 125.8, 125.0, 125.0, 125.0, 124.9, 124.7, 123.1, 79.0,
77.5, 77.1, 76.6, 51.9, 49.9, 40.5, 30.1, 30.0, 28.4, 27.0, 26.7 ppm.
HRMS (ESI): calcd. for C28H34N2NaO2 [M + H]+ 453.2517; found
453.2537.
Compound 8a: Compound 7 (0.5, 1.16 mmol) was dissolved in
CH2Cl2 (2 mL), and TFA (2 mL) was added to the solution. The
mixture was stirred for 4 h. The solvent was removed under reduced
pressure, the residue was dissolved in MeOH (10 mL), TEA
R-2: Synthesized according to the same method. 1H NMR
(300 MHz, CDCl3): δ = 0.76–1.26 (m, 8 H), 0.90 (s, 3 H), 1.22 (s,
(0.2 mL) and phenylmethanamine (0.12 g, 1.16 mmol) were added 24 H), 2.18–2.22 (m, 2 H), 2.35–2.42 (m, 2 H), 3.41–3.45 (m, 1 H),
to the solution, and the mixture was stirred at room temp. over-
night. NaBH4 (0.1 g, 2.63 mmol) was added in small portions, and
the mixture was stirred at room temp. for 4 h. The solvent was
removed under reduced pressure, the residue was taken up with
CH2Cl2, and the organic phase was washed with saturated NaCl
solution (3ϫ50 mL). The organic phase was dried with anhydrous
Na2SO4, concentrated to dryness, and the residue was chromato-
graphed (silica gel; CH2Cl2/MeOH, 10:1, v/v). Compound 8a
3.58–3.60 (m, 2 H), 3.67 (s, 3 H), 3.82–3.89 (m, 2 H), 4.09–4.15 (m,
2 H), 6.73–6.75 (m, 2 H), 7.15–7.31 (m, 8 H), 7.45–7.72 (m, 2 H),
7.88–8.17 (m, 8 H), 8.22–8.27 (m, 1 H) ppm. 13C NMR (75 MHz,
CDCl3): δ = 158.1, 147.9, 146.4, 136.1, 135.5, 133.9, 131.0, 130.6,
129.8, 128.9, 127.5, 126.8, 125.7, 124.7, 124.3, 113.1, 83.6, 57.9,
57.0, 55.9, 55.1, 53.9, 53.1, 49.4, 27.8, 27.5, 25.8, 25.0, 24.9,
19.9 ppm. HRMS (ESI): calcd. for C58H71B2N2O5 [M + H]+
897.5549; found 897.5615. [α]2D2 = –22Ϯ1 (c = 1.0, CH3OH/CH2Cl2
= 1:1).
1
(0.4 g, 82.1%) was obtained as a white solid. H NMR (300 MHz,
1228
www.eurjoc.org
© 2012 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Eur. J. Org. Chem. 2012, 1223–1229